In focus
Latest feed
A Slower Lane for Innovation? FDA Opts for Standard Review of Moderna's mRNA Flu Shot
Moderna's Ambitious mRNA Flu Vaccine Hits a Regulatory Snag
Bridging the Gap: How the US and WHO Are Teaming Up for a Healthier Flu Season and Beyond
A Bumpy Road Ahead? FDA Hits Pause on Moderna's Flu Shot Application
